Alopecia Areata and Vitiligo
Join us in this exciting study to learn more about a new treatment for adults with Alopecia Areata or Vitiligo. We are looking at how safe it is and how well it works.
Study site: Encore Medical Research
- Alopecia areata
- Vitiligo
- Alopecia
- About the Study
- This study aims to find out how safe and effective a new treatment is for adults with Alopecia Areata or Vitiligo. By taking part, you can contribute to important research that may help others in the future.
- What does the study involve?
- You will receive the treatment through an IV infusion.
What to expect
- Placebo
- Everyone receives an active treatment.
- Which treatment you get
- Chosen at random, and you'll know which treatment you get.
- Who can participate?
- We're looking for adults aged 18 and older with moderate to severe Alopecia Areata (more than 20% hair loss) or active Vitiligo. You should not be using certain treatments for these conditions during the study. Think you might qualify? Apply to find out!
Where is the study taking place?
Hollywood
Weston
Boynton Beach
Study details
- Sponsor
- Dren Bio
- Phase
- Phase 1: testing safety in a small group
- Dates
- October 2024 to May 2027 (expected)
- Size
- 81 participants across all sites
- Healthy volunteers
- Only people with the condition
Study details are from ClinicalTrials.gov. The rest of this page is written by the study site for patients and may summarize or reword the registry record, which is the official text. A study listed on ClinicalTrials.gov has not necessarily been reviewed or approved by the U.S. government.
About Encore Medical Research
Encore Medical Research has been serving the South Florida Community since 2017 focusing on phases II through IV clinical trials. Our goal is to provide the highest standard of care to our patients while delivering unmatched performance in our research operations.